Testicular Cancer Forecast in 24 Major Markets 2018-2028

Testicular Cancer Forecast in 24 Major Markets 2018-2028

PR Newswire

DUBLIN, Jan. 12, 2018

DUBLIN, Jan. 12, 2018 /PRNewswire/ --

The "Testicular Cancer Forecast in 24 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This report provides the current incident population for testicular cancer across 24 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Norway, Denmark, Switzerland, Russia, Turkey, Saudi Arabia, South Africa, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current incidence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Testicular cancer is a relatively rare cancer; although it is the most commonly diagnosed cancer in males aged 20-34. There are two main types of testicular cancer; seminomas and non-seminomas, which develop from germ cells in the testicles. The standard treatment procedure involves the complete removal of the testis with the tumour.

Providing a value-added level of insight, several features of testicular cancer patients, as well as the main symptoms and comorbidities of the disease have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of testicular cancer include:

Reasons to Buy:

Key Topics Covered:

  1. Introduction
  2. Cause of the Disease
  3. Risk Factors & Prevention
  4. Diagnosis of the Disease
  5. Variation by Geography/Ethnicity
  6. Disease Prognosis & Clinical Course
  7. Key Comorbid Conditions / Features Associated With the Disease
  8. Methodology for Quantification of Patient Numbers
  9. Additional Data Available on Request
  10. Top-Line Incidence for Testicular Cancer
  11. Features of Testicular Cancer Patients
  12. Tumour Type
  13. Tumour Location
  14. Tumour Dissemination and Staging
  15. Clinical Parameters of Testicular Cancer Patients
  16. Comorbidities of Testicular Cancer Patients
  17. Abbreviations Used in the Report
  18. Other Services & Solutions
  19. Reports & Publications
  20. Online Epidemiology Databases
  21. Online Pharmaceutical Pricing Database
  22. References
  23. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/tgh5k6/testicular_cancer?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Voltar noticias em Inglês